PATENT CLAIM ANALYSIS

Application Number: 15934692
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "089000"]

Abstract:
Disclosed embodiments concern novel interleukin receptor associated kinases (IRAK) inhibitors and compositions comprising such inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent an IRAK-associated disease or condition.

Claim (Index 15):
The composition of  claim 14 , wherein the compound is or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.25641
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15928335', '15136508', '15226625', '15793770', '12657853']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8153063539161736
- 35 USC 102 Novelty (BERT): 0.5666840576196759
- Combined Prediction Score: 0.7904441242865239
- Mean Citation Score: 392.028888
- Max Citation Score: 477.06332
- Similarity Product: 345.0852540820026

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test